Study of a Behavioral Intervention for Older Advanced Cancer Patients and Their Caregivers
Key facts
- Who runs it
- University of Rochester
- Where
- Rochester, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 38 people enrolled
- Started
- 28 Mar 2022
- Ended
- 24 May 2024
- Type of study
- Interventional
- Treatments tested
- Dyadic Life Review (DLR)
- Record updated
- 25 November 2025
Who can take part
- Age
- 50 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Other criteria
- Patient Inclusion Criteria:
- Age ≥ 65
- Able to provide informed consent. All patients will be assessed using the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC) 56 - a score >14.5 will define ability to independently provide informed consent
- Eligible patients have Stage III or IV cancer of any type
- Additionally, at least 20 patients will have a will have a high likelihood of MCI based on screening score of <26 on the Montreal Cognitive Assessment (MoCA) within their eRecord chart
- Able to read and understand English; Patient Exclusion Criteria:
- Patients scoring <14.5 on the UBACC
- Unable to identify caregiver to participate in study; Caregiver Inclusion Criteria:
- One caregiver for each patient will be eligible and must be chosen by the patient. For the purposes of this study, a caregiver is defined as a valued and trusted person in a patient's life who is supportive in health care matters by providing valuable social support and/or direct assistive care
- Caregivers will be selected by the patient when asked if there is a "family member, partner, friend or caregiver with whom you discuss or who can be helpful in health-related matters;" patients who cannot identify such a person ("caregiver") will remain eligible for the study
- Age 50 or older
- Ability to provide consent
- Proficient in English; Caregiver Exclusion Criteria
- Caregivers unable to understand the consent form due to cognitive, health or sensory impairment will be excluded
Where in United States
- University of Rochester Medical CenterRochester, United States
About the trial
What the trial wants to find out
The purpose of this study is to test the feasibility of a telehealth Dyadic Life Review (DLR), adapted from individual Life Review Therapy, with patients and caregivers of older adults with advanced cancer, including those with also Mild Cognitive Impairment (MCI). The study will enroll aim to enroll 20 dyads (pairs) of patients and caregivers (40 total subjects).
The group in the trial
- Total subjectsTreatment being tested
We will enroll dyads (defined as a pair of two people). The dyads are made up of a patient with cancer and their caregiver. The patient and caregiver dyad will go through the Dyadic Life Review intervention together. Dyadic Life Review will consist of 8 sessions delivered by a trained licensed clinician (i.e, the PI or other trained clinician) via video-conferencing in weekly sessions of 60 minutes. Both patients and caregivers will each complete their own measures before and after completing the Dyadic Life Review intervention.
Treatment: Dyadic Life Review (DLR)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Feasibility of a Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Mild Cognitive Impairment (MCI) and Their Caregivers
- Record updated
- 25 November 2025